Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 11
2005 7
2007 3
2008 1
2009 2
2010 4
2011 5
2012 6
2013 7
2014 4
2015 12
2016 21
2017 25
2018 24
2019 24
2020 26
2021 26
2022 33
2023 24
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Results by year

Filters applied: . Clear all
Page 1
Combination of electromagnetic navigation and probe-based LASER endomicroscopy to guide non-solid nodules sampling: Results from the CELTICS 2 study.
Kalifa J, Plat G, Brindel A, Héluain V, Brouchet L, Rouch A, Mazières J, Chapda MP, Villeneuve T, Guibert N. Kalifa J, et al. Among authors: mazieres j. Respir Med Res. 2024 Feb 28;85:101092. doi: 10.1016/j.resmer.2024.101092. Online ahead of print. Respir Med Res. 2024. PMID: 38657300 No abstract available.
Therapeutic bronchoscopy for malignant central airway obstructions caused by non-bronchogenic cancers: Results from the EpiGETIF registry.
Daigmorte C, Usturoi D, Fournier C, Wallyn F, Lorut C, Héluain V, Mazières J, Legodec J, Escarguel B, Egenod T, Cellerin L, Favrolt N, Lachkar S, Crutu A, Briault A, Gut-Gobert C, Bourinet V, Camuset J, Loïc P, Schlossmacher P, Porzio M, Luchez A, Vergnon JM, Pajiep Chapda MC, Roy P, Dutau H, Guibert N. Daigmorte C, et al. Among authors: mazieres j. Respirology. 2024 Apr 18. doi: 10.1111/resp.14723. Online ahead of print. Respirology. 2024. PMID: 38634359 Free article.
A pragmatic guide for management of adverse events associated with lorlatinib.
Liu G, Mazieres J, Stratmann J, Ou SI, Mok T, Grizzard M, Goto Y, Felip E, Solomon BJ, Bauer TM. Liu G, et al. Among authors: mazieres j. Lung Cancer. 2024 Mar 15;191:107535. doi: 10.1016/j.lungcan.2024.107535. Online ahead of print. Lung Cancer. 2024. PMID: 38554546 Free article. Review.
Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study.
Bordet C, Zureik M, Zelmat Y, Lafaurie M, Lapeyre-Mestre M, Sommet A, Mazieres J, Despas F. Bordet C, et al. Among authors: mazieres j. Cancer Treat Res Commun. 2024 Feb 29;39:100801. doi: 10.1016/j.ctarc.2024.100801. Online ahead of print. Cancer Treat Res Commun. 2024. PMID: 38447474 Free article.
STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial.
Baptiste Oudart J, Garinet S, Leger C, Barlesi F, Mazières J, Jeannin G, Audigier-Valette C, Morot-Sibilot D, Langlais A, Amour E, Mathiot N, Birsen G, Blons H, Wislez M. Baptiste Oudart J, et al. Among authors: mazieres j. Lung Cancer. 2024 Apr;190:107508. doi: 10.1016/j.lungcan.2024.107508. Epub 2024 Feb 19. Lung Cancer. 2024. PMID: 38428265 Free article. Clinical Trial.
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.
Remon J, Besse B, Aix SP, Callejo A, Al-Rabi K, Bernabe R, Greillier L, Majem M, Reguart N, Monnet I, Cousin S, Garrido P, Robinet G, Campelo RG, Madroszyk A, Mazières J, Curcio H, Wasąg B, Pretzenbacher Y, Grillet F, Dingemans AC, Dziadziuszko R. Remon J, et al. Among authors: mazieres j. J Clin Oncol. 2024 Apr 20;42(12):1350-1356. doi: 10.1200/JCO.23.01521. Epub 2024 Feb 7. J Clin Oncol. 2024. PMID: 38324744
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer.
Khalifa J, Thébault N, Scarlata CM, Norkowski E, Massabeau C, Brouchet L, Peries Bataille S, Casaroli C, Vaz L, Valle C, Sarot E, Saint-Laurent N, Martin E, Pages PB, Millière A, Mazières J, Cohen-Jonathan Moyal E, Lauzéral-Vizcaïno F, Ayyoub M. Khalifa J, et al. Among authors: mazieres j. Front Oncol. 2023 Nov 22;13:1269166. doi: 10.3389/fonc.2023.1269166. eCollection 2023. Front Oncol. 2023. PMID: 38074683 Free PMC article.
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC.
Kim HR, Awad MM, Navarro A, Gottfried M, Peters S, Csőszi T, Cheema PK, Rodriguez-Abreu D, Wollner M, Yang JC, Mazieres J, Orlandi FJ, Luft A, Gümüş M, Kato T, Kalemkerian GP, Luo Y, Santorelli ML, Pietanza MC, Rudin CM. Kim HR, et al. Among authors: mazieres j. JTO Clin Res Rep. 2023 Sep 9;4(11):100572. doi: 10.1016/j.jtocrr.2023.100572. eCollection 2023 Nov. JTO Clin Res Rep. 2023. PMID: 37954964 Free PMC article.
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC).
Dehem A, Mazieres J, Chour A, Guisier F, Ferreira M, Boussageon M, Girard N, Moro-Sibilot D, Cadranel J, Zalcman G, Ricordel C, Wislez M, Munck C, Poulet C, Gauvain C, Descarpentries C, Wasielewski E, Cortot AB, Baldacci S. Dehem A, et al. Among authors: mazieres j. Lung Cancer. 2023 Dec;186:107393. doi: 10.1016/j.lungcan.2023.107393. Epub 2023 Oct 9. Lung Cancer. 2023. PMID: 37839252
245 results